Your contact person
Manager PR & Communications Jan Phillip Denkers
Eppendorf SE: conversion to European public limited company
"We are convinced that we have taken the right step at the right time with this modern legal form, which is very common in ...
Read more …
Evotec: Collaboration with Bristol Myers Squibb
Evotec SE announced that its collaboration with Bristol Myers Squibb has been expanded to include a new cell type, triggering a payment of $ 9.0 ...
Read more …
Hereon: bone screws that dissolve by themselves
A research team led by the Helmholtz-Zentrum Hereon has now used a 3D X-ray method to determine for the first time quantitatively how different of ...
Read more …
Garz & Fricke Group now part of SECO
This will create Europe's leading provider for IoT and AI solutions in this area. As one of the most important system providers for ARM-based embedded ...
Read more …
Sysmex Europe will relocate its headquarters
The Sysmex Group, international manufacturer and provider of innovative analytical instruments and services for laboratory diagnostics, is on a continuous course of growth and ...
Read more …
Eppendorf Award 2022: Call for Entries
The Eppendorf Award for Young European Investigators, endowed with 20,000 EUR, is granted annually to an early career scientist in Europe for outstanding contributions to ...
Read more …
Cellbox Solutions Establishes Subsidiary in the USA
Cellbox Solutions GmbH, developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market. ...
Read more …
Just - Evotec Biologics opens J.POD® 1 US
Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD® 1 US) in Redmond, Washington. ...
Read more …
Topas Therapeutics Extends Series B
Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today ...
Read more …
Evotec creates long-term growth opportunities
Evotec SE announced that Evotec has added significant opportunities for further, long-term growth by acquiring the Verona site from GlaxoSmithKline SpA (“GSK”). ...
Read more …
New accommodation for XFEL's global researchers
Katharina Fegebank, Senator for Research, Science and Equality in Hamburg, and Friederike Kampschulte, Head of the Science Department at the Ministry of Education, Science and ...
Read more …
Why are alpha and delta faster than wild type?
How do virus variants arise and how do they spread? This is one of the key questions of a new research project initiated jointly by ...
Read more …